(MENAFN- GlobeNewsWire - Nasdaq) Saudi Arabia Non-Invasive Prenatal Testing gains momentum through advanced genomics, safer early screening, healthcare investment, and wider access to genetic testing.Dublin, Oct. 15, 2026 (GLOBE NEWSWIRE) -- "Saudi Arabia Non-Invasive Prenatal Testing Market Report by Component, Application, End User, Cities and Companies Analysis 2026-2034" has been added to ResearchAndMarkets.com's offering.
Saudi Arabia Non-Invasive Prenatal Testing Market Outlook
According to the report, the Saudi Arabia Non-Invasive Prenatal Testing (NIPT) market is projected to increase from US$ 52.50 Million in 2025 to US$ 162.16 Million by 2034. The market is expected to register a Compound Annual Growth Rate (CAGR) of 13.35% from 2026 to 2034, supported by increasing prenatal health awareness, rising maternal age, advances in molecular diagnostics and continued investment in healthcare infrastructure.
Demand for early and accurate screening of fetal chromosomal abnormalities is increasing across the Kingdom. Greater access to specialized maternal healthcare, genetic counseling and advanced laboratory services is also strengthening the adoption of Non-Invasive Prenatal Testing. Government healthcare initiatives, precision medicine programs and the expansion of preventive screening are expected to create further opportunities for laboratories, hospitals and technology providers.
Key Saudi Arabia NIPT Market Growth Drivers
Technological advancement remains a central market driver. Improvements in next-generation sequencing (NGS), molecular diagnostics, bioinformatics and laboratory automation have enhanced the accuracy, reliability and scope of prenatal genetic screening. Advanced platforms increasingly support screening for Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), Patau syndrome (Trisomy 13), sex chromosome abnormalities, microdeletions and selected inherited conditions. Faster processing, reduced testing errors and improved workflow efficiency are helping healthcare institutions expand their prenatal screening capabilities.
Rising maternal age is also contributing to demand. Social and economic changes, including higher educational attainment, career development and evolving family planning preferences, have increased the number of pregnancies among women in their thirties and later. As chromosomal abnormality risks rise with maternal age, healthcare professionals are increasingly recommending accurate prenatal risk assessment, particularly for high-risk pregnancies.
Saudi Arabia's prevalence of genetic and inherited disorders is encouraging greater emphasis on preventive healthcare and early screening. NIPT adoption is expanding among patients with a family history of inherited conditions, previous pregnancy complications or other clinical risk factors. Continued investment in genetic testing capacity and specialized maternal care is expected to support sustained market development.
Market Challenges
Limited awareness and uneven access to genetic counseling remain important barriers. Some expectant parents lack sufficient information about the clinical value, capabilities and limitations of NIPT, which can delay decision-making or reduce participation in prenatal screening programs. Differences in healthcare knowledge and service availability between regions may also lead to unequal adoption. Expanded patient education, healthcare provider engagement and access to qualified counseling will be important for broader market penetration.
Instruments and Services
The Saudi Arabia NIPT instruments market is benefiting from increased investment in next-generation sequencing systems, polymerase chain reaction (PCR) platforms, sample preparation equipment and bioinformatics solutions. Hospitals, diagnostic laboratories and specialized genetic testing centers are modernizing their capabilities to improve analytical accuracy, processing speed and laboratory efficiency.
The services segment is expanding as prenatal genetic screening becomes more integrated into maternal care. Specialized diagnostic laboratories, maternity centers and hospitals are increasing access to testing and counseling, while improved turnaround times are strengthening patient and physician confidence. Hospitals are expected to remain a major end-user segment because of their role in patient consultation, sample collection, clinical follow-up and pregnancy management.
Down syndrome screening represents a significant application within the Saudi Arabia Non-Invasive Prenatal Testing market. Rising maternal age, stronger prenatal health awareness and improved access to genetic testing are increasing demand for Trisomy 21 risk assessment. Screening for Edwards syndrome, Patau syndrome, Turner syndrome and other chromosomal conditions also contributes to market expansion.
Programs and Competitive Developments
King Faisal Specialist Hospital & Research Centre has expanded preventive fetal screening and advanced prenatal genomics programs using NIPT and NGS technologies. These initiatives are strengthening screening capacity and supporting the detection of a broader range of genetic diseases. The Saudi NIPT Expert Consortium has also supported a national adoption roadmap intended to encourage wider implementation across healthcare institutions.
International companies are expanding technologies, testing portfolios and laboratory support within the Saudi market. Active participants include Eurofins Scientific, F. Hoffmann-La Roche Ltd, Invitae Corporation, Illumina Inc., Natera Inc., Centogene NV and Qiagen. Competitive activity includes sequencing-based NIPT deployment, prenatal testing service expansion, molecular diagnostic workflow development and broader availability of screening panels through regional healthcare providers.
Regional Market Highlights
Riyadh is expected to remain Saudi Arabia's largest and most advanced NIPT market. The capital benefits from a concentration of specialist hospitals, maternity centers, diagnostic laboratories and professionals trained in prenatal genetics and fetal medicine. Public and private healthcare investment continues to improve access to advanced molecular diagnostics and prenatal screening services.
Jeddah is another major market, supported by an extensive network of hospitals, maternity clinics and private healthcare providers. Collaboration between healthcare institutions and diagnostic laboratories is improving the availability and timeliness of genetic testing. The city's large and diverse population is expected to sustain demand for prenatal screening.
Dhahran and Dammam are emerging NIPT markets in the Eastern Province. Dhahran benefits from modern medical facilities, corporate healthcare programs, specialized clinics and growing access to genetic counseling. Dammam's expanding hospital and diagnostic center network is supporting the integration of genetic screening into prenatal care. Healthcare modernization, patient education and laboratory investment are expected to drive continued growth in both cities.
Saudi Arabia NIPT Market Segmentation
Component: Instruments, Kits and Reagents, and Services Application: Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), Patau Syndrome (Trisomy 13), Turner Syndrome, and Other Applications End User: Hospitals and Diagnostic Labs Cities: Riyadh, Jeddah, Dammam, Dhahran, Jubail, Khobar, Tabuk, Mecca, Medina, and Rest of Cities
The report evaluates key market participants through company overviews, key personnel, recent developments, SWOT analysis and revenue analysis. Overall, Saudi Arabia's focus on healthcare modernization, early diagnosis and precision medicine is expected to strengthen the role of Non-Invasive Prenatal Testing in maternal and fetal healthcare through 2034.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment